The impact of early exercise intervention on the incidence and severity of lymphedema following axillary lymph node dissection in breast cancer.
코호트
1/5 보강
PICO 자동 추출 (휴리스틱, conf 3/4)
유사 논문P · Population 대상 환자/모집단
136 patients who underwent ALND between 2020 and 2024.
I · Intervention 중재 / 시술
ALND between 2020 and 2024
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
It significantly enhances physical function and QoL, particularly in high-risk populations. These findings support integrating individualized exercise programs into routine postoperative rehabilitation pathways.
[BACKGROUND] Breast cancer-related lymphedema (BCRL) is a chronic complication of axillary lymph node dissection (ALND) that impairs mobility and quality of life (QoL).
- 표본수 (n) 70
- p-value P=0.03
- p-value P=0.02
- 연구 설계 cohort study
APA
Wang M, Zhang X, et al. (2026). The impact of early exercise intervention on the incidence and severity of lymphedema following axillary lymph node dissection in breast cancer.. Gland surgery, 15(3), 60. https://doi.org/10.21037/gs-2025-1-597
MLA
Wang M, et al.. "The impact of early exercise intervention on the incidence and severity of lymphedema following axillary lymph node dissection in breast cancer.." Gland surgery, vol. 15, no. 3, 2026, pp. 60.
PMID
41969945
Abstract
[BACKGROUND] Breast cancer-related lymphedema (BCRL) is a chronic complication of axillary lymph node dissection (ALND) that impairs mobility and quality of life (QoL). This study evaluated the impact of early systematic exercise on BCRL incidence, severity, and functional recovery.
[METHODS] A retrospective cohort study analyzed 136 patients who underwent ALND between 2020 and 2024. The intervention group (n=70) participated in a therapist-guided, phased exercise program initiated within two weeks post-surgery. The control group (n=66) received conventional health education. The primary outcome was BCRL incidence within 12 months (defined as ≥10% or ≥200 mL volume increase). Secondary outcomes included shoulder range of motion (ROM), [Disabilities of the Arm, Shoulder, and Hand (DASH) score] scores, pain [Visual Analog Scale (VAS) score], and QoL [European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 and breast cancer module (EORTC QLQ-C30/BR23)].
[RESULTS] The overall BCRL incidence was 25.0%. The intervention group showed a significantly lower incidence compared to controls (17.1% 33.3%, P=0.03). Multivariate analysis confirmed early exercise as an independent protective factor [odds ratio (OR) =0.42, 95% confidence interval (CI): 0.20-0.88, P=0.02] and significantly delayed the time to BCRL onset [hazard ratio (HR) =0.52, P=0.04]. In the intervention group, patients experienced significantly reduced severity of lymphedema, characterized by smaller limb volume differences (95±120 165±140 mL, P=0.01) and a lower proportion of moderate-to-severe cases (5.7% 18.2%). These patients also demonstrated superior functional recovery, with greater shoulder flexion and abduction ROM (P<0.01) and lower DASH scores (12.4±8.6 18.1±10.3, P=0.002), alongside enhanced well-being evidenced by lower median pain scores (VAS 1 2, P=0.02) and higher QLQ-C30 QoL scores (78.5±12.0 72.0±13.5, P=0.008). Subgroup analysis revealed the greatest benefits for high-risk patients [radiotherapy, high body mass index (BMI), ≥15 lymph nodes dissected]. No serious exercise-related adverse events occurred.
[CONCLUSIONS] Early, systematic exercise intervention after ALND is a safe and effective strategy to reduce BCRL risk and severity. It significantly enhances physical function and QoL, particularly in high-risk populations. These findings support integrating individualized exercise programs into routine postoperative rehabilitation pathways.
[METHODS] A retrospective cohort study analyzed 136 patients who underwent ALND between 2020 and 2024. The intervention group (n=70) participated in a therapist-guided, phased exercise program initiated within two weeks post-surgery. The control group (n=66) received conventional health education. The primary outcome was BCRL incidence within 12 months (defined as ≥10% or ≥200 mL volume increase). Secondary outcomes included shoulder range of motion (ROM), [Disabilities of the Arm, Shoulder, and Hand (DASH) score] scores, pain [Visual Analog Scale (VAS) score], and QoL [European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 and breast cancer module (EORTC QLQ-C30/BR23)].
[RESULTS] The overall BCRL incidence was 25.0%. The intervention group showed a significantly lower incidence compared to controls (17.1% 33.3%, P=0.03). Multivariate analysis confirmed early exercise as an independent protective factor [odds ratio (OR) =0.42, 95% confidence interval (CI): 0.20-0.88, P=0.02] and significantly delayed the time to BCRL onset [hazard ratio (HR) =0.52, P=0.04]. In the intervention group, patients experienced significantly reduced severity of lymphedema, characterized by smaller limb volume differences (95±120 165±140 mL, P=0.01) and a lower proportion of moderate-to-severe cases (5.7% 18.2%). These patients also demonstrated superior functional recovery, with greater shoulder flexion and abduction ROM (P<0.01) and lower DASH scores (12.4±8.6 18.1±10.3, P=0.002), alongside enhanced well-being evidenced by lower median pain scores (VAS 1 2, P=0.02) and higher QLQ-C30 QoL scores (78.5±12.0 72.0±13.5, P=0.008). Subgroup analysis revealed the greatest benefits for high-risk patients [radiotherapy, high body mass index (BMI), ≥15 lymph nodes dissected]. No serious exercise-related adverse events occurred.
[CONCLUSIONS] Early, systematic exercise intervention after ALND is a safe and effective strategy to reduce BCRL risk and severity. It significantly enhances physical function and QoL, particularly in high-risk populations. These findings support integrating individualized exercise programs into routine postoperative rehabilitation pathways.
같은 제1저자의 인용 많은 논문 (5)
- Rutin targets PD-L1 for the treatment of atopic dermatitis: network pharmacological analysis and experimental evidence.
- Associations of electronic health literacy with related factors in individuals diagnosed with colorectal cancer: a cross-sectional analysis.
- Perioperative penpulimab-based combination therapy in patients with resectable non-small cell lung cancer (ALTER-L043): an open-label, multicenter, randomized, phase II trial.
- The research advances of crosstalk between cancer-associated fibroblasts and tumor cells using co-culture organoids.
- The gene-panel obtained by anti-PD-1 monotherapy for melanoma reveals prognostic markers and therapeutic targets.